Lori La Bey welcomes back Sharon L. Rogers, the CEO of AmyriAD Therapeutics. Sharon was previously chief of research at Eisai, where she played a leading role in developing Aricept, the top-selling Alzheimer's medication on the market.

Learn:

1. Who is really funding early-stage trials?
2. What is the difference between Pharma and Social Therapies?
3. Do we know how many forms of dementia there are?
4. What does having a complex dementia mean?
5. Does a change in diagnosis affect a clinical trial?
6. About the Domino’s Study.
7. Will there be a silver bullet medication for dementia in the near future?

 

Listen and Subscribe to Alzheimer’s Speaks on Apple Podcast

https://podcasts.apple.com/us/podcast/alzheimers-speaks/id986940432

 

Listen and Subscribe to Alzheimer’s Speaks on Spotify

https://open.spotify.com/show/255okRnEgfCUqXq1NWcrT3

  

Contact AmyriAD Therapeutics

Website      https://amyriadtherapeutics.com/

LinkedIn      https://www.linkedin.com/company/amyriad-therapeutics/

Twitter        https://twitter.com/AmyriAD_Tx

 

Contact Lori La Bey with questions or branding needs at https://www.alzheimersspeaks.com/

Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sound news, not just sound bites since 2011.

Alzheimer's Speaks is part of the Senior Resource Podcast Network

 

Support this Show: https://alzheimersspeaks.com/donate-now/

See omnystudio.com/listener for privacy information.